Stock OBIO ORCHESTRA BIOMED HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Orchestra BioMed Holdings, Inc.

Equities

OBIO

US68572M1062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
5.3 USD +1.53% Intraday chart for Orchestra BioMed Holdings, Inc. +1.73% -41.95%
May. 13 Earnings Flash (OBIO) ORCHESTRA BIOMED HOLDINGS Reports Q1 Revenue $620,000 MT
May. 13 Orchestra BioMed Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
ORCHESTRA BIOMED HOLDINGS, INC. Stock Orchestra BioMed Holdings, Inc.
-41.95% 190M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+10.03% 223B
B
DANAHER CORPORATION Stock Danaher Corporation
+13.59% 195B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+20.01% 144B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.83% 111B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.05% 65.01B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+15.38% 53.02B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 50.45B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+8.37% 44.15B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.27% 36.45B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. OBIO Stock
  4. Ratings Orchestra BioMed Holdings, Inc.